Histologically, the tumor showed the typical morphology and immune profile of an epithelioid malignant PEComa, i.e., co-expression of myogenic and melanocytic markers, such as desmin, Melan-A, and HMB45. The gene discussed is PMEL; the disease is neoplasm.